Systemic sclerosis (SSc) is characterized by excessive production of collagens by fibroblasts that leads to vast fibrosis. Resistance to apoptosis is one of the possible underlying mechanisms of fibrosis in these patients. Survivinis involved in inhibition of apoptosis and aberrantly functions in SSc. Since dysregulation of survivin-targeting microRNAs (miRNAs) has frequently been observed in cancer and some autoimmune disorders, this study aimed to investigate their expression status in dermal fibroblasts from SSc patients.
INTRODUCTION
Systemic sclerosis (scleroderma, SSc) is an autoimmune fibrotic disorder that mostly affects the skin and internal organs with a progressive course and fatal outcome. 1, 2 Although the exact etiology of SSc has not been characterized, it has been proposed that environmental factors through epigenetic bridge cause disease in genetically predisposed individuals. 3, 4 Clinical manifestations of SSc include various vascular dysfunctions, immune abnormalities, and fibrosis, mediated by various molecules and pathways. 5, 6 After tissue injury, fibroblasts tilt homeostasis towards producing collagens and differentiating into myofibroblasts. 7 In opposition to normal wound healing, which is terminated by tissue contraction and cell apoptosis, unknown stimuli keep fibroblasts activated with decreased susceptibility to apoptosis. Afterwards, excessive collagen production by these long-lived cells causes fibrosis in the affected tissues. [8] [9] [10] [11] One of the specific mediators that is responsible for apoptosis resistance is the inhibitor of apoptosis (IAP) protein family. IAP proteins are essential for cell survival by targeting caspase enzymes as central mediators in apoptosis pathways. Survivin (also known as BIRC5) is an IAP member and plays a dual role in promoting cell cycle and inhibiting apoptosis. 12, 13 The critical role of survivin in cell division is inferred from its sharp expression at Gap2/Mitosis (G2/M) phases due to inactivation of a cell cycle regulator called cyclin-dependent kinase (Cdk) 4. 14 Although the underlying mechanisms are unclear, studies have shown the apoptosis-regulating role of survivin. 15 Survivinhas gained much attention in SSc research 16, 17 and previously unpublished data by our lab along with another findings pointed out to the higher survivin expression in these patients. 18 . MicroRNAs (miRNAs) are small (about 22 nucleotides) noncoding RNAs that regulate their target mRNAs post-transcriptionally through degradation or translational repression. They exert their effects by binding to complementary sequences in 3′-untranslated regions (3′-UTR) of mRNAs. 19 miRNAs have vastly been surveyed in autoimmunity. 4, 20, 21 Among the transcription factors, signaling molecules and ligands as well as other regulatory mechanisms of surviving expression, 22 the role of miRNAs in survivin modulation has received increasing attention in the field of cancer 23 and several critical survivin-targeting miRNAs have been identified to date. 23 The role of miR-218 in survivin regulation has been reported in lung, breast, and nasopharyngeal cancers. [24] [25] [26] Moreover, miR-320a is involved in the profibrotic signaling pathways in pathogenesis of SSc and cancers through targeting the β-Catenin, 27 a downstream cellular protein in Wingless-type (Wnt) pathway. 28 Data has shown that miR-320a promotes apoptosis by targeting survivin and downregulated miR-320a is a possible mechanism of tumorigenesis in colorectal cancer. 27 miR-16-5p induces leukemic cell apoptosis through the negative regulation of B-cell lymphoma 2 (Bcl-2), an anti-apoptotic protein. 29 miR-16-5p targets survivin and p53, a nuclear protein which controls cell cycle and apoptosis. Data from renal cancer investigations suggest that the tumor-suppressive role of miR-708-5p is mediated through survivin downregulation. 30 It was also noted that this miRNA induces its proapoptotic effect by caspase induction. 31 It was observed that survivin was decreased in miR-542-3p-transfected cells, implying to the interaction of miR-542-3p with target survivinmRNA.
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Considering the higher expression of the apoptosis inhibitory molecule of survivin in SSc patients, and relentless characteristics of SSc fibroblasts in apoptosis, the current study examined expression levels of five predicted and confirmed survivin-targeting miRNAs. This could be beneficial in discovering the regulatory mechanisms of survivin expression and hopefully lead to devising new therapeutics in SSc medications.
MATERIALS AND METHODS

Patients and Control Subjects
Ten 
Isolation and Culture of Fibroblasts
Three-millimeter skin punch biopsy specimens were obtained from the affected forearms of the participants under local anesthesia. Tissues were then transferred in Hank's balanced salt solution (HBSS) containing antibiotic-antimycotic (Sigma, USA) vials to the laboratory. By enzymatic action of Dispase II and Collagenase type I, fibroblasts were isolated from skin biopsy samples. Then the isolated cells were propagated in T-75 cell culture flasks (SPL, Korea) containing Dulbecco's modified Eagle medium (DMEM) (Gibco, UK) supplemented with 10% heatinactivated fetal bovine serum (FBS) (Gibco, UK) and 100 U/ml penicillin-streptomycin. Confluent detached fibroblasts with trypsin (Sigma, USA) were used after three passages.
Immunocytochemical Analysis of Skin Biopsies
The purity of fibroblast cultures was confirmed using immunocytochemical staining. To this end, cultured cells at a density of 5×10 4 cells in 24-well tissue culture plates were fixed with pre-cold methanol, rendered permeable using Triton-X100 treatment and blocked with 1% bovine serum albumin (BSA) (Sigma, USA). Then, cells were probed with primary antibodies (anti-α smooth muscle actin (α-SMA, Abcam) and antifibroblast surface protein (ab11333, Abcam). Afterward, fibroblasts were washed three times with PBS and subsequently incubated in secondary antibody (Sheep Anti-Mouse Ig (Human Ig Adsorbed) FITC conjugated, Avicenna Research Institute, ACECR, Iran).Ultimately, labeled cells were mounted in DAPIcontaining medium (sc-24941, Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. Fluorescence was visualized using a digital inverted microscope (Nikon, Japan).
RNA Extraction and cDNA Synthesis
The seeded cells in T-75 flask culture plates were collected using trypsinization. Then, the enzymatic reaction in the flasks was neutralized through adding 10% FBS supplemented DMEM solution. To isolate the total RNA content, including large coding and small non-coding RNAs (such as microRNAs) from the collected cells, miRNeasy Mini kit (Qiagen, Valencia, CA, USA) was used following the manufacturer's manual. The quantity and purity of total RNA were evaluated using a NanoDrop-2000c Spectrophotometer (ThermoScientific, Wilmington, Delaware, USA), and the criterion for the RNA inclusion was 260/280.
Using miScript II RT kit (Qiagen, Valencia, CA, USA), cDNA was generated from 1 µg of RNA. In summary, reactions were carried out in the final volume of 20 µl using a Peqlab thermal cycler (Peqlab Biotechnology GmbH, Erlangen, Germany). Briefly, each reaction consisted of 6 μL5x miScript HiSpec buffer, 2 μL 10x nucleics mix, 2 μL miScript Reverse Transcriptase, and remaining RNase-free water. Samples were incubated for 60 min at 37 °C and then for 5 min at 95°C to inactivate the miScript Reverse Transcriptase Mix.
Survivin Is A miRNA Target gene
To identify putative miRNAs which target survivin, the miRNA target sites in 3′-UTR region of the survivin mRNA were screened using miRBase (http://www.mirbase.org) and microRNA databases (http://www.microrna.org). miR-16-5p, miR-218-5p, miR-320a, miR-542-3p, and miR-708-5p were selected to be evaluated in experimental phase (Table 1) .
Real-Time Quantitative Polymerase Chain Reaction
This study investigated the expression of survivin mRNA and five survivin-targeting miRNAs in the dermal fibroblasts of SSc patients. Quantifications were performed using the StepOnePlus real-time PCR System (Applied Biosystems, USA). The expression data of survivin mRNA and miRNAs were normalized using B2M mRNA and U6 snRNA as endogenous controls, respectively. The comparative C T method was used to calculate the relative expressions in samples. 34 Relative quantification of miRNAs (miR-16-5p, miR-218-5p, miR-542-3p, miR-708-5p, and miR-320a) was achieved according to protocol by the miScript SYBR Green PCR Kit. Each reaction mixture contained 12.5 μL2x QuantiTect SYBR Green PCR Master Mix,1.8 μL10x miScript Universal Primer, 1.8μL10x miScript Primer Assay, diluted cDNA, and a corresponding amount of RNase-free water to the final volume of 25 μL. Reactions were initiated with 15 min incubation at 95°C for Hot Start Taq DNA Polymerase activation followed by 40 cycles of 15 s denaturing at 94°C, 30 s annealing at 55°C, and 30 s at 70°C for extension. 
Statistical Analysis
All statistical analyses were carried out using SPSS version 21.0 (SPSS Inc, IL, USA) and GraphPad Prism version 5 (La Jolla, CA, USA) softwares. Comparisons between two groups was conducted using the MannWhitney U test. The correlations between survivin mRNA and miRNAs expression profiles or each miRNA was analyzed using Spearman's Rank-Order. p<0.05 was considered as statistically significant.
RESULTS
Survivin mRNA was significantly overexpressed (Fold change=1.85) in fibroblasts from SSc patients as compared with controls (Table 2) .
Among the five miRNAs, only miR-542-3p and miR-708-5p demonstrated statistically significant aberration in expression level in fibroblasts from SSc patients compared with healthy subjects (Table 2) . Notably, the miR-542-3p expression level in fibroblasts from SSc group was significantly downregulated in comparison to control group (Fold   change= -2, p=0.033) .Additionally, miR-708-5p was significantly overexpressed in patients than in healthy individuals (Fold change=2.53; p=0.05) .
No correlation was found with respect to the expression level of miRNAs and clinical manifestations, especially MRSS. Moreover, the expression levels of all miRNAs, except than miR-542-3p, had no significant correlation with survivin mRNA expression level (Table 3) . A significant negative correlation (r=−0.45, p=0.049) was observed between miR-542-3p level and survivin mRNA expression.
DISCUSSION
Skin lesions from SSc patients contain fibroblasts that show uncontrolled proliferation ability and produce higher matrix deposition. For many years, researchers supposed that the presence of some growth factors stimulate these cells to proliferate uncontrollably. 35 Since fibroblast proliferation has been seen in other non-fibrotic conditions, researchers have focused on the elimination of these cells as a mechanism of pathogenesis as well as therapeutic approach. 9 Previous studies have shown a decreased susceptibility to apoptosis in SSc fibroblasts. 36 With this regard, the role of IAP proteins, particularly survivin, has been specified in some autoimmune diseases and cancers. 23, 37, 38 Chen et al. 37 reported elevated expression levels of survivin in untreated rheumatoid arthritis (RA) patients versus normal individuals. Specifically, in the field of SSc, several studies have emphasized on the role of survivin. 18, 39 As shown in a study by Mokuda et al., 18 only survivin expression differed in skin lesions and peripheral blood mononuclear cells (PBMCs) of SSc patients. The current study also investigated the expression levels of survivin in SSc patients. However, unlike Mokuda et al. study, which covered both SSc disease types, this study only focused on diffuse SSc patients to provide homogenous samples needed for statistically valid results. The data was significantly similar to prior findings about the modulation of survivinm RNA in other fibrotic conditions. 40 Despite the observed change in survivin expression, the mechanism of its regulation in SSc is poorly understood. Recent studies have focused on the role of epigenetics such as miRNAs in skin-involved autoimmune diseases specially SSc. 41, 42 Furthermore, dysregulated survivin-targeting miRNAs have provided new perspectives in the field of cancer. 23 Therefore, much more needs to be learned about the regulatory role of survivin-targeting miRNAs in SSc. Herein, we hypothesized to evaluate miR-16-5p, miR-218-5p, miR-542-3p, miR-708-5p, and miR-320a, which were previously implicated to be involved in apoptosis through direct binding to survivin mRNA. 23 The role of miR-218 in survivin regulation has been reported in lung, breast, and nasopharyngeal cancers. [24] [25] [26] In nasopharyngeal carcinoma, downregulated miR-218 due to epigenetic silencing of its promoters was associated with survivin overexpression. This overexpression is the main culprit of cell survival and poor prognosis in nasopharyngeal carcinoma. 26 Another survivin-targeting miRNA is miR-320a, which targets β-Catenin. 27 It has been proposed that β-Catenin, a downstream cellular protein in Wingless-type (Wnt) pathway, is involved in the profibrotic signaling pathways in disease processes like SSc and cancers. 28 Data has shown that miR-320a
promotes apoptosis by targeting survivin as one of the β-Catenin downstream genes. 27 miR-16-5p induces leukemic cell apoptosis through the negative regulation of B-cell lymphoma 2 (Bcl-2), an anti-apoptotic protein. 29 In this regard, miR-16-5p targets p53, a nuclear protein which controls cell cycle and apoptosis, and survivin. Surprisingly, P53 can affect miR-16-5p maturation and upregulation, which in turn represses survivin expression. 43 This is the first study addressing the expression profile of survivin-targeting miRNAs in SSc pathogenesis. Results revealed that the expression of miR-542-3p was significantly downregulated in dermal fibroblasts of SSc group in comparison with the control group. The findings of the current study support the previously published data about the association between miR-542-3p and survivin. 44 Yoon et al. 44 validated survivin as a direct target of miR-542-3p. As revealed in their luciferase activity assay, cotransfection of miR-542-3p with survivin resulted in decreased activity of the reporter. They found that, by utilizing survivin siRNA, similar levels of inhibition could be achieved. The analysis of neuroblastoma cell lines in the study by Althoff et al. 45 indicated a negative correlation between survivin expression and miR-542-3p, which is similar to the current results. They also synthesized miR-542-3p-loaded nanoparticles in order to test the therapeutic potential of this miRNA. These nanoparticles induced apoptosis and decreased cell proliferation through survivin reduction. 45 Another finding established the association of survivin with miR-542-3p in osteoblast differentiation. Bone morphogenetic protein (BMP)-7, one of the important mediators of osteogenesis, is another direct target of miR-542-3p. It should be noted that miR-542-3p suppresses osteogenic differentiation by blocking BMP-7 and its downstream signaling molecules like survivin. 46 According to the current web-based analysis, another miRNA that significantly changes in fibroblasts is miR-708-5p. As an almost recently identified miRNA, 47 little has been studied with regard to the implication of miR-708-5p in human disorders. Studies of the function of miR-708-5p in renal cell carcinomas demonstrated that this miRNA was involved in apoptosis and modulate the tumorigenesis of renal cells. 30, 48 miR-708-5p has been evaluated in cancers mainly and was observed to be upregulated in childhood acute lymphoblastic leukemia 49 and lung carcinoma. 50 In renal cell carcinoma, 30 an enhanced apoptosis was seen after survivin knockdown which was also observed when miR-708-5p was transfected. Contrary to those results, no correlation between miR-708-5p and survivin was found in this study. A hypothesis to explain this observation is that miR-708-5p might be upregulated as a compensatory response to suppress survivin expression after downregulation of miR-542-3p. However, it is highly complicated to analyze the disease in a certain time point to validate this contemplation, in which miR-708-5p is upregulated later to cover the absence of miR-542-3p in repressing the survivin mRNA. As expected, decreased miR-542-3p led to higher survivin expression levels in SSc fibroblasts. This regulation can be considered as one possible cause of apoptosis resistance in this disease. Since miR-542-3p has three binding sites on the survivin gene, this miRNA could act more specifically than others as a therapeutic target. 23 The study team recommends further research to be conducted to gain bright insight into the function and plausible therapeutic application of miR-542-3p in SSc. This investigation may be subject to some limitations and caveats. The protein level of survivin was not evaluated in our study that could be functionally important in evaluating consequence of miRNA dysregulation. Furthermore, the validation study of miRNA expression dysregulation was not conducted that could be helpful in gaining a better understanding of the role of miRNAs in determining the pathogenesis of SSc.
In conclusion, the data in the current study indicates that miR-542-3p has a pro-apoptotic role which is mediated by the regulation of surviving mRNA expression. As this miRNA is downregulated in SSc fibroblasts, overexpression of survivin may contribute to apoptosis resistance in these cells. Considering the current concentrations in the application of miRNAs as therapeutic tools in treatment of a variety of human disorders, it appears miR-542-3p is of promising potential to be further investigated and hopefully led to a medication in SSc treatment.
